"What Washington wants in Cures 2.0"** Reps. Diana DeGette and Larry Bucshon are advancing "Cures 2.0," legislation building on the 2016 21st Century Cures Act, aimed to enhance health data sharing, FDA approval processes, and research. The follow-up aims to address pandemic prevention and better data governance, with industry lobbyists suggesting specific improvements in these areas. Organizations such as AHIP, the American Health Information Management Association, and others provided feedback emphasizing the importance of unlocking health data to improve outcomes and reduce costs.